Davis Rea LTD. Has $12.28 Million Stake in Synopsys, Inc. $SNPS

Davis Rea LTD. lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 0.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 23,943 shares of the semiconductor company’s stock after acquiring an additional 75 shares during the quarter. Synopsys makes up about 3.0% of Davis Rea LTD.’s investment portfolio, making the stock its 10th largest position. Davis Rea LTD.’s holdings in Synopsys were worth $12,275,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in SNPS. Cornerstone Planning Group LLC raised its position in shares of Synopsys by 275.0% during the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company’s stock worth $25,000 after acquiring an additional 44 shares during the last quarter. Saudi Central Bank bought a new stake in Synopsys in the first quarter valued at about $26,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in Synopsys by 441.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 53 shares during the last quarter. Independence Bank of Kentucky increased its holdings in Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 30 shares during the last quarter. Finally, WPG Advisers LLC bought a new stake in Synopsys in the first quarter valued at about $34,000. Institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the company’s stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the sale, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. This trade represents a 32.48% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,894 shares of company stock worth $16,760,783. Corporate insiders own 0.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Bank of America reiterated an “underperform” rating and issued a $525.00 price objective (down previously from $625.00) on shares of Synopsys in a report on Wednesday, September 10th. Wells Fargo & Company dropped their price objective on Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a report on Wednesday, September 10th. JPMorgan Chase & Co. cut their price objective on Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Wednesday. Finally, The Goldman Sachs Group cut their price objective on Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $575.31.

Synopsys Price Performance

Shares of SNPS opened at $438.92 on Friday. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The business has a 50-day simple moving average of $544.01 and a two-hundred day simple moving average of $510.12. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. The stock has a market cap of $81.53 billion, a PE ratio of 34.45, a PEG ratio of 5.34 and a beta of 1.10.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the company earned $3.43 EPS. Synopsys’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.